ANL CIK: 1944552

Adlai Nortye Group Ltd.

  • Singapore
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.03
FY22:
−43.2
FY23:
−56.7
FY24:
−51.8
FY25:
−33.5
Change from FY21 to FY25
millions USD
FY21:
−54.9
FY22:
28.4
FY23:
−11.0
FY24:
28.1
FY25:
−15.6
Change from FY21 to FY25
millions USD
FY21:
97.2
FY22:
−6.78
FY23:
116
FY24:
−6.58
FY25:
−3.81
millions USD
FY21:
39.3
FY22:
−21.6
FY23:
48.6
FY24:
−30.3
FY25:
−52.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.05
FY22:
−44.5
FY23:
−56.9
FY24:
−52.0
FY25:
−33.6

All amounts in millions USD Data source:SEC EDGAR